Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
601-615 of 2993 results
Luminex starts Aries GBS assay clinical trials
By MDBR Staff Writer
Luminex has started clinical and analytical trials to assess its Aries Group B Streptococcus (GBS) assay.
Diagnostics > In Vitro Diagnostics > News
Bio-Techne to buy control solutions provider Cliniqa
By MDBR Staff Writer
Bio-Techne has agreed to purchase Cliniqa, which manufactures and markets quality controls, calibrators and bulk reagents used in the clinical diagnostic market.
Diagnostics > In Vitro Diagnostics > News
Roche’s cobas Cdiff Test receives FDA 510(k) approval
By MDBR Staff Writer
Switzerland-based Roche has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.
Diagnostics > In Vitro Diagnostics > News
ArcherDX launches two new FusionPlex panels
By MDBR Staff Writer
ArcherDX expanded its Archer FusionPlex assay menu to include the FusionPlex Lung Thyroid Panel and FusionPlex Solid Tumor Panel.
Diagnostics > In Vitro Diagnostics > News
Exact Sciences and MD Anderson Cancer Center to develop screening and diagnostic tests for lung cancer
By MDBR Staff Writer
Exact Sciences and The University of Texas MD Anderson Cancer Center announced an agreement to jointly develop and commercialize blood-based screening and diagnostic tests for the early detection of lung cancer
Diagnostics > In Vitro Diagnostics > News
Chembio obtains CE mark approval for DPP HIV 1/2 assay
By MDBR Staff Writer
US-based point-of-care (POC) diagnostic tests provider Chembio Diagnostics has received CE mark approval for its DPP HIV 1/2 assay.
Diagnostics > In Vitro Diagnostics > News
Bruker launches new Maldi Tissuetyper solution
By MDBR Staff Writer
US-based Bruker has introduced new Maldi Tissuetyper solution, which facilitates use of rapifleX Maldi-TOF Mass Spectrometry system for anatomical pathology research.
Diagnostics > In Vitro Diagnostics > News
Studies presented at 2015 ASCO meeting demonstrate predictive power of bioTheranostics’ BCI molecular test
By MDBR Staff Writer
bioTheranostics announced results from studies being presented at the 2015 American Society of Clinical Oncology (ASCO) meeting reinforcing the role its Breast Cancer Index (BCI) molecular test plays in informing decisions about extending endocrine therapy beyond five years post-diagnosis for patients with early stage, estrogen receptor-positive (ER+) breast cancer.
Diagnostics > In Vitro Diagnostics > News
Transgenomic introduces new EGFR CLIA test
By MDBR Staff Writer
Transgenomic has introduced the new Multiplexed Ice Cold PCR (MX ICP) CLIA service for mutation detection in cancer patients, which will help in more informed diagnoses, better treatment decisions and ongoing patient monitoring.
Diagnostics > In Vitro Diagnostics > News
Myriad significantly advances myChoice HRD companion diagnostic test
By MDBR Staff Writer
Myriad Genetics announced new clinical studies on its myChoice HRD companion diagnostic test at the 2015 American Society of Clinical Oncology annual meeting being held in Chicago, Ill.
Diagnostics > In Vitro Diagnostics > News
Halozyme and Roche’s Ventana to develop new companion diagnostic assay
By MDBR Staff Writer
Halozyme Therapeutics has signed an agreement with Roche Group member Ventana Medical Systems to develop a companion diagnostic assay for cancer treatment.
Diagnostics > In Vitro Diagnostics > News
Cinven to acquire medical diagnostics provider Labco for €1.2bn
By MDBR Staff Writer
UK-based private equity firm Cinven has agreed to acquire French medical diagnostics provider Labco from a consortium of investors, for around €1.2bn.
Diagnostics > In Vitro Diagnostics > News
FDA grants 510(k) approval for Roche’s cobas Cdiff Test
By MDBR Staff Writer
Switzerland-based Roche has received 510(k) approval from the US Food and Drug Administration (FDA) for its cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.
Diagnostics > In Vitro Diagnostics > News
InDevR launches enhanced flu vaccine potency assay
By MDBR Staff Writer
InDevR announced the launch of the VaxArray Influenza potency assay, a new and re-branded version of the company's Influenza Titer on Chip or Flu-ToC product.
Diagnostics > In Vitro Diagnostics > News
Biodesix introduces GeneStrat test for NSCLC
By MDBR Staff Writer
Molecular diagnostics firm Biodesix has introduced GeneStrat, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC).
Diagnostics > In Vitro Diagnostics > News
601-615 of 2993 results